课题基金 / 基金详情

DIETARY AND PHARMACOLOGIC INTERVENTIONS TO INHIBIT OXIDATION OF LDL

DIETARY AND PHARMACOLOGIC INTERVENTIONS TO INHIBIT OXIDATION OF LDL
抑制 LDL 氧化的饮食和药物干预
批准号：
5221271
负责人：
Peter D Reaven
金额：
$0.0万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/5221271
关键词：
clinical research diet therapy dietary lipid human subject human therapy evaluation low density lipoprotein macrophage monocyte noninsulin dependent diabetes mellitus nutrition related tag oxidation superoxides unsaturated fatty acids

项目摘要

项目成果

Peter D Reaven的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To test the hypothesis that in NIDDM, replacement of diets high in saturated fatty acids with diets high in mufa (and low in pufa) will have potentially useful effects on plasma levels of lipoproteins and LDL particle size distribution, susceptibility to oxidative modification of LDL and LDL subfractions, measures of total body lipid peroxidation and monocyte fatty acid composition and ability of monocytes and monocyte-derived macrophages to generate superoxide anion and to oxidize LDL.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Role for Glycemic Variation in Optimizing Management of Diabetes and Vascular Complications
A Role for Glycemic Variation in Optimizing Management of Diabetes and Vascular Complications
  • 批准号：
    10040813
  • 项目类别：
  • 资助金额：
    $12.28万
  • 财政年份：
    2020
  • 负责人：
    Peter D Reaven
  • 依托单位：
    UNIVERSITY OF ARIZONA
Apolipoprotein-C Proteoforms in Dyslipidemia and Cardiovascular Disease
Apolipoprotein-C Proteoforms in Dyslipidemia and Cardiovascular Disease
海外基金